This inventor holds 1 USPTO granted patent. Top assignee: Massachusetts Institute of Technology. Active years: 1996.
Company Filing History:
Years Active: 1996
Title: David J Kuter: Innovator in Blood Platelet Therapies
Introduction
David J Kuter is a prominent inventor based in Reading, MA (US). He has made significant contributions to the field of medical therapies, particularly in the treatment of blood platelet disorders. His innovative work has the potential to improve patient outcomes and advance medical science.
Latest Patents
David J Kuter holds a patent for a method of using megapoietin to prolong the survival and viability of blood platelets. This patent describes new therapies for treating blood platelet disorders based on the megapoietin gene and protein. The patent outlines additional utilities for megapoietin, such as increasing the storage life of platelet and whole blood preparations. It also details methods for selectively targeting therapeutic or imaging agents to arterial clots and stimulating platelet production from megakaryocytes in vivo and in vitro. This innovation serves as a potential source of platelets for transplantation and stimulates stem cell growth.
Career Highlights
David J Kuter is affiliated with the Massachusetts Institute of Technology, where he continues to contribute to research and development in his field. His work has garnered attention for its potential applications in medical therapies and patient care.
Collaborations
Throughout his career, David has collaborated with notable colleagues, including Robert D Rosenberg and David L Beeler. These collaborations have furthered research and innovation in the medical field.
Conclusion
David J Kuter's contributions to the field of blood platelet therapies exemplify the impact of innovative thinking in medicine. His work not only addresses critical health issues but also paves the way for future advancements in treatment options.